Details for New Drug Application (NDA): 090931

NDA 090931 describes TAMSULOSIN HYDROCHLORIDE, which is a drug marketed by Alkem Labs Ltd, Ascent Pharms Inc, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Impax Labs, Macleods Pharms Ltd, Norvium Bioscience, Sandoz, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Wockhardt, and Zydus Pharms Usa Inc, and is included in fourteen NDAs. It is available from forty-three suppliers. Additional details are available on the TAMSULOSIN HYDROCHLORIDE profile page.

The generic ingredient in TAMSULOSIN HYDROCHLORIDE is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.

Summary for 090931

Tradename:	TAMSULOSIN HYDROCHLORIDE
Applicant:	Sun Pharm Inds Ltd
Ingredient:	tamsulosin hydrochloride
Patents:	0

Pharmacology for NDA: 090931

Mechanism of Action

Adrenergic alpha-Antagonists

Suppliers and Packaging for NDA: 090931

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	090931	ANDA	Aphena Pharma Solutions - Tennessee, LLC	43353-019	43353-019-30	30 CAPSULE in 1 BOTTLE (43353-019-30)
TAMSULOSIN HYDROCHLORIDE	tamsulosin hydrochloride	CAPSULE;ORAL	090931	ANDA	Aphena Pharma Solutions - Tennessee, LLC	43353-019	43353-019-53	60 CAPSULE in 1 BOTTLE (43353-019-53)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	0.4MG
Approval Date:	Jul 15, 2010	TE:	AB	RLD:	No

Complete Access Available with Subscription